Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Primary Care POC Diagnostics Market From 2025 To 2029?
In past years, there has been a notable expansion in the primary care point-of-care (poc) diagnostics market. It is projected to surge from $16.35 billion in 2024 to $17.38 billion in 2025, with the compound annual growth rate (CAGR) estimated at 6.3%. Factors contributing to this growth during the historic period include the rising incidence of chronic illnesses, the movement towards personalized healthcare, increased healthcare spending, supportive regulatory structures and faster approval procedures, as well as an increased focus on early detection and preventive measures for diseases.
The market for primary care POC diagnostics is projected to witness robust expansion in the coming years, with expectations to climb to$22.88 billion in 2029 at a CAGR of 7.1%. Factors contributing to the growth within the forecast period includes the occurrence of infectious disease outbreaks, broadening applications in non-communicable disease sectors, escalating acceptance in home healthcare systems, progress in precision medicine initiatives, increase in healthcare infrastructural investments, amplified disease burden, and rising consciousness about the critical role of disease detection in its early stages. Key trends in the forecast period encompass the application of artificial intelligence (AI) and machine learning algorithms, developments in molecular diagnostics technologies, miniaturization and increased portability of POC diagnostic instruments, integration with smart devices, and the increasing employment of multiplexing and panel testing within POC diagnostics.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp
What Are the Core Growth Drivers Propelling the Primary Care POC Diagnostics Market Forward?
The increasing occurrence of infectious diseases is anticipated to spur the growth of the primary care POC diagnostics market in the future. Infectious diseases, which are caused by disease-causing microorganisms such as bacteria, viruses, fungi, or parasites, can spread from one person to another directly or indirectly through various contact mediums such as contaminated surfaces, air, water, or through vectors like insects. The rising incidence of infectious diseases can be attributed to factors like unfavorable environmental conditions, urbanization, resistance to antimicrobial drugs, and inadequate immunization coverage. Primary care POC diagnostics play a crucial role in fighting against infectious diseases as it allows for early detection, prompt treatment, and effective disease containment strategies in various healthcare settings. For instance, a report in October 2023 by the UK Health Security Agency, a UK-based government body responsible for managing public health security, revealed that the number of HIV diagnoses in England saw a 22% rise from 3,118 in 2021 to 3,805 in 2022. In addition, in November 2023, the World Health Organization (WHO), a Switzerland-based agency of the United Nations responsible for global public health, stated that approximately 10.6 million cases of tuberculosis (TB) were reported worldwide in 2022, impacting 5.8 million men, 3.5 million women, and 1.3 million children. Hence, the increasing prevalence of infectious diseases is fostering the growth of the primary care POC diagnostics market.
What Segment Types Define the Primary Care POC Diagnostics Market Structure?
The primary care poc diagnosticsmarket covered in this report is segmented –
1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products; Coagulation Testing Products; Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Hematology Testing Products; Drug-Of-Abuse (DOA) Testing Products; Other Products
2) By Prescription: Prescription Based; Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Other End-Uses
Subsegments:
1) By Glucose Monitoring: Blood Glucose Meters; Continuous Glucose Monitoring (Cgm) Systems; Test Strips For Glucose Meters; Glucose Control Solutions
2) By Cardiometabolic Testing Products: Blood Pressure Monitors; Lipid Profile Testing Kits; Hemoglobin A1c Testing Kits; Ecg Or Ecg Monitors; Hba1c Point-Of-Care Devices
3) By Infectious Disease Testing Products: Rapid Strep Tests; Influenza (Flu) Testing Kits; Covid-19 Rapid Tests; Hiv Rapid Testing Kits; Hepatitis Testing Kits; Malaria Rapid Diagnostic Tests (Rdts); Other Infectious Disease Tests
4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits; International Normalized Ratio (Inr) Monitors; Activated Partial Thromboplastin Time (Aptt) Testing Kits; Coagulation Control Solutions; Whole Blood Coagulation Monitors
5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based); Ovulation Prediction Kits; Pregnancy Test Strips; Fertility Monitoring Devices
6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits; Cea (Carcinoembryonic Antigen) Testing Kits; Ca-125 (Ovarian Cancer Marker) Kits; Her2 Testing Kits; Other Tumor Marker Test Kits
7) By Cholesterol Testing Products: Total Cholesterol Testing Kits; Ldl Or Hdl Testing Kits; Triglyceride Testing Kits; Point-Of-Care Lipid Panel Devices
8) By Hematology Testing Products: Hemoglobin Test Kits; Hematocrit Testing Kits; Complete Blood Count (Cbc) Kits; Point-Of-Care Hematology Analyzers; Hemoglobin A1c Testing Devices
9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests; Oral Fluid Drug Tests; Saliva-Based Drug Tests; Blood-Based Drug Tests; Breath Alcohol Tests
10) By Other Products: Allergy Testing Kits; Urinalysis Test Strips; Vitamin And Mineral Deficiency Testing Kits; Point-Of-Care Liver Function Tests; Kidney Function Testing Products; Blood Gas Testing Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Primary Care POC Diagnostics Market?
North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing thePrimary Care POC Diagnostics Industry Evolution?
Leading enterprises involved in the primary care POC diagnostics arena are concentrating on incorporating advanced technology solutions like portable point-of-care RT-PCR instruments to escalate their market revenue. These portable POC RT-PCR devices are small, easy-to-move gadgets engineered to carry out real-time reverse transcription polymerase chain reaction (RT-PCR) tests outside conventional lab environments. For example, Genes2Me Pvt. Ltd., a molecular diagnostic solutions firm based in India, introduced its Rapi-Q Point of Care RT PCR system geared towards diseases like HPV and tuberculosis in October 2022. The system is promoted as simple to operate, presenting quicker outcomes in under 45 minutes, and has an eight-well layout with four fluorescent channels. The portable and lightweight nature of the Rapi-Q system renders it appropriate for venues such as hospitals, blood banks, health clinics, research labs, and airports. The device delivers excellent sensitivity, precision, and efficacy in identifying a range of illnesses and is adaptable with over 50 lyophilized, room-temperature disease detection kits.
View the full report here:
https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report
What Is the Definition of the Primary Care POC Diagnostics Market?
A primary care point-of-care (POC) diagnostic is a medical test or assessment performed conveniently and quickly within a primary care setting, such as a doctor’s office or a clinic, without requiring specialized equipment or extensive laboratory processing. These diagnostics are designed to provide rapid results, allowing healthcare providers to make timely decisions about patient care during the initial consultation.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15642
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model